Références

Sources des 35 études impliquant plus de 2 000 patients


  1. Scadding GK, Durham SR, Mirkian R, et al. BSACI guidepnes for the management of rhinosinusitis and nasal polyposis. Cpn Exp Allergy 2007 ;38 :260‐275.
  2. Anand VK. Epidemiology and economic impact of rhinosinusitis. Ann Otol Rhinol Laryngol 2004 ; 193 (Suppl) : 3‐5.
  3. Shashy RG, Moore EH, Weaver A. prevalence of the chronic sinusitis diagnosis in Olmsted County, Minnesota. Arch Otolaryngol Head Neck Surg 2004 ;130 :320‐323.
  4. Chen Y, Dales R, pn M. The epidemiology of chronic rhinosinusitis in Canadians. Laryngoscope 2003 ; 113 :1199‐1205.
  5. Hickner JM, Bartlett JG, Besser RE, et al. principles of appropriate antibiotic use for acute rhinosinusitis in adult : background. Ann Intern Med 2001 ; 134 :498‐505.
  6. Macdonald KI, McNally JD, Massoud E. The health resource utipzation of Canadians with chronic rhinosinusitis. Laryngoscope 2009 ; 119 : 184‐189.
  7. Fokkens W, Lund V, Bachert C, et al. EAACI position paper on rhinosinusitis and nasal polyps. Allergy 2005 ; 60 : 583‐601.
  8. Fokkens W, Lund V, Mullol J, et al. Ep3OS 2007 : European position paper on rhinosinusitis and nasal polyps. Rhinology 2007 ; 45 : 1‐139.
  9. Osguthorpe JD. Adult rhinosinusitis : diagnosis and management. Am Fam physician 2001 ; 63 : 69‐ 76.
  10. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis : estabpshing definitions for cpnical research and patient care. J Allergy Cpn Immunol 2004 ; 114 : S155‐S212.
  11. 11.Hadley JA, Schaeler SD. Cpnical evaluation of rhinosinusitis : history and physical examination. Otolaryngol Head Neck Surg 1997 ; 117 (3pt 2) : S8‐S11.
  12. Kryukov AI, Kunelskaya NL, Turovsky AB, Artemyev ME, Ibragimova ZS. New perspectives in non‐ invasive treatment of sinusitis. Bulletin Otorinolaringology 2007;(2):33‐7.
  13. Sinuforte®. Cpnical pharmacology documentation (data on file, Hartington pharma Ltd)
  14. Baraniuk JN. Neural regulation of mucosal function. pulmonary pharmacol Ther 2008; 21: 442‐ 448.
  15. Lund VJ. Therapeutic targets in rhinosinusitis : infection or inflammation? Medscape J Med 2008; 10 : 105.
  16. Fabre M. Effects of cyclamen extract on cell osmosis. New Horizons in the non‐invasive management of sinonasal disorders. International ENT medical summit, Barcelona, 19th September, 2007.
  17. Ashworth MA. Variations in antibiotic prescribing and consultation rates for acute respiratory infection in UK general practices 1995‐2000. Br J Gen pract 2005; 55: 603‐608.
  18. Anon. A randomized, double‐bpnd, placebo‐controlled, parallel groupv trial of Cyclamen europaeum extract nasal spray in the treatment of subjects with acute sinusitis. Integrated Cpnical and Statistical Report December 31st, 2008, (data on file, Hartington pharma Ltd).
  19. Anders C, Hörmann K, Kpmek L, pfaar O. Cpnical evaluation of a new approach in acute rhinosinusitis. Rhinology World 2009, philadelphia (oral presentation).
  20. Mullol J. Are all forms of ARS cured in 4 weeks? Evidence of the prosinus study. presented at the 22nd European Rhinology Society (ERS) and the 27th International Symposium of Infection and Allergyof the Nose (ISIAN), Crete, Greece, 2008
  21. Rybak AA, Matveyeva TV, Neprin VG. Effect of Sinuforte® on quapty of pfe of patients with sinusitis, (data on fi le, Hartington pharma Ltd).
  22. Bereziuk VV, Chernokur AA. Use of SINUFORTE® in the management of acute rhinosinusitis and secretory otitis in children, (data on file, Hartington pharma Ltd).
  23. printz OM, Bashek V. Study of the use of Sinuforte® in the treatment of children with inflammatory conditions of the paranasal sinuses, (data on fi le, Hartington pharma Ltd).
  24. Chernisheva p, Siniachenko VV. Cpnical‐immunological study of the efficacy of Sinuforte® in children with acute sinusitis. J Otolaryngol Dis (Kiev) 2004: Special Edition
  25. Jorissen M.postoperative care following endoscopic sinus surgery. Rhinology 2004; 42 : 114‐120.
  26. popovich VI, Staiden EB, Savchuk OI. Dynamics of the transport and heating function indices of the mucous membrane of the nasal cavity in the early postoperative management of patients with chronic rhinosinusitis. Rhinology 2007; 3: 56‐62.
  27. Doñamayor C. Spanish experience in postoperative care with cyclamen. New Horizons in the non‐ invasive management of sinonasal disorders. International ENT medical summit, Barcelona, 19th September, 2007.
  28. petrova LG. Treatment of exudative otitis media with Sinuforte®/Nasodren®/Fluirespira forte® (extract of cyclamen europaeum). ESpO June, 2008; 8th International Conference of the European Society of paediatric Otorhinolaryngology, Budapest (poster).
  29. Khetchinashvip S, Gotsadse K. Effi cacy of the salpingoparanasal secretion stimulant Sinuforte® in acute otitis media, (data on file,Hartington pharma Ltd).
  30. Khetchinashvip S, Gotsadse K. Effi cacy of the salpingoparanasal secretion stimulant Sinuforte®/Nasodren®/Fluirespira forte® (extract of cyclamen europaeum)in acute otitis media. ESpO June 2008; 8th International Conference of the European Society of paediatric Otorhinolaryngology, Budapest (poster).
  31. Bezshapochny SB. Results of the use of Sinuforte® in the treatment of acute purulent rhinosinusitis, (data on file, Hartington pharma Ltd).
  32. Klossek JM, Federspil p. Update on treatment quidepnes for acute bacterial sinusitis. J Cpn pract 2005; 59: 230‐238.
  33. Zacharek MA, Malani pN, Benninger MS. An approach to the diagnosis and management of acute bacterial rhinosinusitis. Expert Rev Anti Infect Ther 2005; 3: 271‐278.
  34. National Center for Health Statistics. Chronic sinusitis : morbidity, (Accessed on March 26th from http://www.cdc.gov/nchs/fastats/sinuses.htm).
  35. ponikau J, Hamilos D, Barreto A, Cecil J, Jones S, Manthei S. An exploratory trial of Cyclamen europaeum extract for acute rhinosinusitis. Laryngoscope, June, 2012. pMID: 22675486

Références du site

Source photos des sinus : http://www.nasodren.com/en/media1.html

Référence interne du support : Site Internet Nasodren F12 RCS Nanterre 542044656

Dispositif Medical de Classe I

Date de création : Juin 2012